nach oben

Breast Cancer Research and Treatment

Erschienen in:

01.06.2019 | Brief Report

Radiation oncology crossword: breast cancer

verfasst von: Shearwood McClelland III, Ryan M. Rhome, Richard C. Zellars

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

This is presented as a continuation of our homage to the original Radiation Oncology crossword, updated to reflect the changes in our field in the quarter century since [1]. Following our recent focus on the central nervous system and genitourinary cancer, the focus of this edition is breast cancer [2, 3]. …

Gagnon JD (1995) Radiation oncology crossword. Int J Radiat Oncol Biol Phys 32:263–264CrossRefPubMed

McClelland S 3rd, Jaboin JJ, Thomas CR Jr (2018) Radiation oncology crossword: central nervous system. Int J Radiat Oncol Biol Phys 100:1300–1303CrossRefPubMed

McClelland S 3rd, Mitin T, Thomas CR Jr (2019) Radiation oncology crossword: genitourinary cancer. Rep Pract Oncol Radiother 24:281–283CrossRefPubMed

Bristol IJ, Woodward WA, Strom EA et al (2008) Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 72:474–484CrossRefPubMedPubMedCentral

Bartelink H, Horiot JC, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259–3265CrossRefPubMed

Bijker N, Meijnen P, Peterse JL et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381–3387CrossRefPubMed

Poortmans PM, Collette S, Kirkove C et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317–327CrossRefPubMed

Ratosa I, Jenko A, Oblak I (2018) Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning. Radiol Oncol 52:233–244CrossRefPubMedPubMedCentral

Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1:888–896CrossRefPubMed

10.

Correa C, McGale P, Taylor C et al (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162–177CrossRefPubMed

11.

Katz A, Strom EA, Buchholz TA et al (2000) Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18:2817–2827CrossRefPubMed

12.

National Comprehensive Cancer Network. Breast Cancer (Version 1.2019) https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 25 May 2019

13.

Fouad TM, Barrera AMG, Reuben JM et al (2017) Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. Lancet Oncol 18:e228–e232CrossRefPubMedPubMedCentral

14.

Morrow M, Van Zee KJ, Solin LJ et al (2016) Society of surgical oncology-American society for radiation oncology-American society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol 6:287–295CrossRefPubMedPubMedCentral

15.

Shapiro CL, Recht A (2001) Side effects of adjuvant treatment of breast cancer. N Engl J Med 344:1997–2008CrossRefPubMed

16.

Ho AL, Bovill ES, Macadam SA, Tyldesley S, Giang J, Lennox PA (2014) Postmastectomy radiation therapy after immediate two-stage tissue expander/implant breast reconstruction: a University of British Columbia perspective. Plast Reconstr Surg 134:1e–10eCrossRefPubMed

17.

Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N (2004) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 100:238–244CrossRefPubMed

18.

Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106CrossRefPubMed

19.

Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998CrossRefPubMed

20.

Pezner RD, Schultheiss TE, Paz IB (2008) Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys 71:710–713CrossRefPubMed

21.

Jagsi R, Griffith KA, Boike TP et al (2015) Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol 1:918–930CrossRefPubMed

22.

Coles CE, Griffin CL, Kirby AM et al (2017) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet 390:1048–1060CrossRefPubMedPubMedCentral

Titel: Radiation oncology crossword: breast cancer
verfasst von: Shearwood McClelland III
Ryan M. Rhome
Richard C. Zellars
Publikationsdatum: 01.06.2019
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 1/2019
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-019-05304-x

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Radiation oncology crossword: breast cancer

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

The use of contralateral prophylactic mastectomy among elderly patients in the United States

Prognostic role of immune infiltrates in breast ductal carcinoma in situ

Sharing in care: engaging care partners in the care and communication of breast cancer patients

Breast cancer outcome prediction with tumour tissue images and machine learning

Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis

The impact of distinct triple-negative breast cancer subtypes on misdiagnosis and diagnostic delay

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie